Skip to content
Recall Observatory FDA recall evidence

Drug product

Ceftazidime, Sterile Ophthalmic Solution for Injection, Preservative Free (11.25 mg/0.5 mL (22.5 mg/mL), 0.5mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446, NDC 05446-0733-01

D-0397-2022

December 06, 2021

Class II

Product summary

Firm
Edge Pharma, LLC
Event
Event 89172
Status
Terminated
Classification
Class II
Quantity
168 syringes
Official record key
drug-enforcement:D-0397-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: 09-2021-01@6 12/14/2021 & 10-2021-27@4 01/01/2022

Distribution pattern: nationwide

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility